Tag: Eisai Co Ltd

Health

European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai

July 26, 2024
Newseum Global

[ad_1] European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating…

Business

Biogen tops profit estimates as cost cuts take hold, Alzheimer’s drug Leqembi launch picks up

April 24, 2024
Newseum Global

[ad_1] A test tube is seen in front of displayed Biogen logo in this illustration taken…

Health

These health-care companies see opportunity ahead from Alzheimer’s drug approval

July 28, 2023
Barnali Pal

[ad_1] As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs,…

Health

Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know

July 8, 2023
Barnali Pal

[ad_1] The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on…

Health

FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage

July 8, 2023
Barnali Pal

[ad_1] The Food and Drug Administration on Thursday fully approved the Alzheimer’s treatment Leqembi, a pivotal…

Business

Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024

July 7, 2023
Barnali Pal

[ad_1] Jay Reinstein, who suffers from Alzheimer’s, receives an injection so he can have a PET…